Series B - Orna Therapeutics
Investment Firm
Overview
Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.
Announced Date
Aug 16, 2022
Closed on Date
Aug 16, 2022
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
3
| Investor Name |
|---|
Round Details and Background
Orna Therapeutics raised $221000000 on 2022-08-16 in Series B
Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 24, 2021 |  Series A - Orna Therapeutics | 8 | - | 80.0M |
| Jan 01, 2020 | Seed Round - Orna Therapeutics | 1 | - | 20.0M |
| Aug 16, 2022 | Series B - Orna Therapeutics | 3 | - | 221.0M |
Recent Activity
There is no recent news or activity for this profile.